Nonclinical Toxicology and Biocompatibility Program Supporting Clinical Development and Registration of the Port Delivery System With Ranibizumab for Neovascular Age-Related Macular Degeneration - Vladimir Bantseev, Joshua Horvath, Giulio Barteselli ...
Implant Reduces Treatment Burden in Wet Macular Degeneration
Ranibizumab Implant For nAMD Requires Only Two Treatments a Year
Long-Acting Anti-VEGF Delivery
Evaluation of Port Delivery System with ranibizumab for the treatment of neovascular age-related macular degeneration | Therapeutic Delivery
Port Delivery System is noninferior to monthly ranibizumab injections - American Academy of Ophthalmology
Figure of the port delivery system (PDS) implant with dimensions of... | Download Scientific Diagram
Port Delivery System - EyeWiki
Use of the Port Delivery System in AMD - Retina Today
The Port Delivery System with ranibizumab—journey of mitigating vitreous hemorrhage | Eye
Optometric Management - July 2020
Port Delivery System with ranibizumab (PDS) implant. A, Port Delivery... | Download Scientific Diagram
SUSVIMO™ (ranibizumab injection) Device
Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
Implanted drug 'reservoir' safely reduces inj | EurekAlert!
Refill-Exchange Procedure of the Port Delivery System With Ranibizumab: Overview and Clinical Trial Experience | Ophthalmic Surgery, Lasers and Imaging Retina
How SUSVIMO™ (ranibizumab injection) Works for nAMD
Retinal Physician - Tips and Tricks for the Port Delivery System
Nonclinical Toxicology and Biocompatibility Program Supporting Clinical Development and Registration of the Port Delivery System With Ranibizumab for Neovascular Age-Related Macular Degeneration - Vladimir Bantseev, Joshua Horvath, Giulio Barteselli ...
Archway phase 3 trial of the Port Delivery System with ranibizumab (PDS) for neovascular AMD: end-of-study results
Long-Acting Anti-VEGF Delivery
Retina Global - Vision outcomes using a port delivery system proved equivalent to ranibizumab injections and showed a positive benefit profile. #PDS #nAMD #antiVEGF http://bit.ly/3nqW8aS | Facebook
Targeting Unmet Needs in nAMD Treatment
Ophthalmology Management - SUSTAINED ANTI-VEGF DELIVERY
New implant technology safely minimizes injections for people with macular degeneration
